Hepatitis C ups liver cancer risk, study confirms

NEW YORK (Reuters Health) - The risk of a rare form of liver cancer called intrahepatic cholangiocarcinoma, which occurs in the bile ducts of the liver, is significantly elevated in individuals who are infected with hepatitis C virus (HCV), according to a large “case-control” study of US veterans.

HCV-infected individuals are also at increased risk for another type of liver cancer called hepatocellular carcinoma, the study shows. Liver cancer is the third leading cause of cancer deaths worldwide.

The findings stem from a look at 146,394 HCV-infected and 572,293 uninfected adults, mostly men, who were followed for an average of more than 2 years.

When comparing HCV-infected with HCV-uninfected subjects, the risk of hepatocellular carcinoma was 15-fold higher in the infected group and the risk of intrahepatic cholangiocarcinoma was 2.5-fold higher. The risk of pancreatic cancer was 23 percent higher.

Analyses adjusting for other variables, such as alcohol use and inflammation of the pancreas), confirmed the strong association between HCV infection and hepatocellular carcinoma and intrahepatic cholangiocarcinoma. However, the association between HCV and pancreatic cancer was no longer statistically significant.

Dr. Hashem B. El-Serag, at the Houston VA Medical Center, and colleagues there and at the National Cancer Institute in Rockville, Maryland, say the mixed findings of this study regarding the association between HCV and pancreatic cancer “merit additional investigation.”

“From a clinical perspective,” they conclude, “early intervention strategies, including screening HCV-positive individuals earlier or more rigorously, may improve the outcomes for both hepatocellular carcinoma and intrahepatic cholangiocarcinoma.”

SOURCE: Hepatology, January 2009.


Related Posts:

NEW YORK (Reuters Health) - Patients with hepatocellular carcinoma (HCC) have a significantly higher prevalence of type 2 diabetes mellitus (DM) compared to the general population, according to findings from a case-control study conducted in Italy. “The association of type (DM2) … with hepatocellular carcinoma (HCC) has been long suspected,” Dr. Valter Donadon, at Pordenone Hospital,

Full Post: Liver cancer patients have high diabetes prevalence

NEW YORK (Reuters Health) - Surgical removal of the kidney — a procedure known as nephrectomy — improves survival in patients with locally advanced renal cell carcinoma, the most common form of kidney cancer. Dr. Pierre I. Karakiewicz from University of Montreal and colleagues determined survival rates for 43,143 patients treated with nephrectomy for advanced renal

Full Post: Surgery improves kidney cancer survival: study

NEW YORK (Reuters Health) - A large waist circumference, which is known to raise the risk of cardiovascular disease, may also raise the risk of stroke or mini-stroke, researchers from Germany report. A large waistline seems to be a better indicator of a person’s risk for suffering a stroke or mini-stroke, also known as “transient ischemic

Full Post: Large waist size a good predictor of stroke risk

NEW YORK (Reuters Health) - People who undergo liver transplantation, particularly children, are at increased risk for developing cancer, Finnish researchers report in the journal Liver Transplantation. “On the basis of our data,” Dr. Fredrik Aberg, from the Helsinki University Central Hospital, and co-authors note, “1 of 6 liver transplant patients is estimated to develop some

Full Post: Cancer common after liver transplantation

By Megan Rauscher NEW YORK (Reuters Health) - Obesity surgery, also known as bariatric surgery, not only helps obese individuals shed a significant amount of weight, it also significantly improves or completely resolves a common obesity-related liver problem known as non-alcoholic fatty liver disease, a review of published studies shows. So-called “non-alcoholic fatty liver disease” is an

Full Post: Liver disease may resolve with weight loss surgery

Site Navigation

Most Read



  • kinwrite.com@gmail.com